Avastin

January 10, 2018

Study Aims to Identify Women with Ovarian Cancer Who May Benefit from Maintenance Treatment

News

Myriad Genetics and AstraZeneca have expanded their collaboration to conduct a study to identify women with advanced ovarian cancer who may benefit from maintenance treatment with Lynparza (olaparib) and Avastin ... Read more

October 2, 2017

Tesaro Shares Multitude of Ovarian Cancer Treatment Findings at Madrid Conference

News

Half of ovarian cancer patients in a small study responded to a combination of Tesaro’s Zejula and Genentech’s Avastin, according to a presentation Tesaro made at the European Society of Medical Oncology (ESMO) 2017 ... Read more

December 8, 2016December 8, 2016

FDA’s Approval of Avastin for Ovarian Cancer Offers New Hope, Treatment Option

News

The U.S. Food and Drug Administration (FDA) approved Genentech’s Avastin in combination with chemotherapy for the treatment of platinum-sensitive recurrent ovarian cancer (psOC). This marks the first new psOC treatment option ... Read more